A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures Read more about A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures
Financial Impact of HSA-HDHP Reform to Improve Access to Chronic Disease Management Medications Read more about Financial Impact of HSA-HDHP Reform to Improve Access to Chronic Disease Management Medications
Study of U.S. Commercial Health Plans Shows Widespread Variation in Coverage and Reimbursement for Specialty Medicines Read more about Study of U.S. Commercial Health Plans Shows Widespread Variation in Coverage and Reimbursement for Specialty Medicines
Prioritizing Health Care Spending: Engaging Employees in Health Care Benefit Design Read more about Prioritizing Health Care Spending: Engaging Employees in Health Care Benefit Design
Little Consistency in Evidence Cited by Commercial Health Plans for Specialty Drug Coverage Read more about Little Consistency in Evidence Cited by Commercial Health Plans for Specialty Drug Coverage
Pharmacy Benefits: Super-sized, Minimized or Right-Sized? Read more about Pharmacy Benefits: Super-sized, Minimized or Right-Sized?
When Is It Less Acceptable for Patients to Face Higher Cost-Sharing? Read more about When Is It Less Acceptable for Patients to Face Higher Cost-Sharing?
Incorporating What Matters to Patients in Quality Measures: A Discussion With NPAF’s Dr. Balch Read more about Incorporating What Matters to Patients in Quality Measures: A Discussion With NPAF’s Dr. Balch
Same Condition, Different Costs: Should Patients Pay Different Amounts? Read more about Same Condition, Different Costs: Should Patients Pay Different Amounts?
NPC in Chain Drug Review: Should Patients With the Same Condition Bear Different Costs? Read more about NPC in Chain Drug Review: Should Patients With the Same Condition Bear Different Costs?